Drug‐induced liver injury as assessed by the updated Roussel Uclaf Causality Assessment Method following mild COVID‐19 in a patient under anastrozole therapy—A case report
Cancer Reports · 2024-04 · 7 (4)
DOI: 10.1002/cnr2.2028 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cancer Reports, online erschienen am 05.04.2024. Verfasst von Wolfgang Lischka und 1 weiteren Autor:innen. Beteiligte Einrichtung: Private Practice, Gumpoldskirchen, Austria. Hauptthemen laut MEDLINE: COVID-19, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Anastrozole is a selective aromatase inhibitor used for the treatment of postmenopausal hormone‐sensitive breast cancer. The major side effects include osteoporosis, hypercholesterolemia, and musculoskeletal events, such as arthralgia and myalgia. Other adverse events are rare, including symptoms of acne, masculinization, and drug‐induced liver injury, with the latter reported in a few cases only. Case Here, we report on a patient under anastrozole therapy who developed drug‐induced liver injury as assessed by the updated Roussel Uclaf Causality Assessment Method 5 weeks after a mild SARS‐CoV‐2 infection, which is, to the best of our knowledge, the first report of its kind involving anastrozole. Discontinuation of anastrozole resulted in a marked improvement of the alanine aminotransaminase, and aspartate aminotransaminase as well as normalized lactate dehydrogenase serum levels already seen after 26 days. Surprisingly, however, the cholestatic serum markers gamma‐glutamyl transpeptidase and alkaline phosphatase showed a further rise, and took another 4 weeks to drop significantly.
Conclusion
The presentation of this case is meant to alert physicians to a potential drug‐induced liver injury following mild SARS‐CoV‐2 infection in patients under anastrozole medication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Private Practice, Gumpoldskirchen, Austria.
- Department of Medical Genetics, Yerevan State Medical University, Yerevan, Armenia.
ORCID-Profile: Gernot Kriegshäuser
Zitieren
APA
Lischka, W., & Kriegshäuser, G. (2024). Drug‐induced liver injury as assessed by the updated Roussel Uclaf Causality Assessment Method following mild COVID‐19 in a patient under anastrozole therapy—A case report. Cancer Reports, 7(4). https://doi.org/10.1002/cnr2.2028
Vancouver
Lischka W, Kriegshäuser G. Drug‐induced liver injury as assessed by the updated Roussel Uclaf Causality Assessment Method following mild COVID‐19 in a patient under anastrozole therapy—A case report. Cancer Reports. 2024;7(4). doi:10.1002/cnr2.2028
BibTeX
@article{Lischka2024,
author = {Lischka, Wolfgang and Kriegshäuser, Gernot},
title = {Drug‐induced liver injury as assessed by the updated Roussel Uclaf Causality Assessment Method following mild COVID‐19 in a patient under anastrozole therapy—A case report},
journal = {Cancer Reports},
year = {2024},
volume = {7},
number = {4},
doi = {10.1002/cnr2.2028}
}
EUVIMED